Complete failure of block3 · Adult patients undergoing hand, wrist or forearm surgery
Double showed no clear difference in complete failure of block3 compared with single‐injection technique (low certainty).
1 finding from 1 review
Time to readiness for surgery2 (minutes) · Adult patients undergoing hand, wrist or forearm surgery
1 finding from 1 review
Adverse effects lasting more than 24 hours3 · Adult patients undergoing hand, wrist or forearm surgery
1 finding from 1 review
Primary anaesthesia failure · Adult patients undergoing hand, wrist or forearm surgery
Multiple leads to lower primary anaesthesia failure compared with single‐injection technique (high certainty).
1 finding from 1 review
Secondary analgesia failure: Intraoperative sedation required · Adult patients undergoing hand, wrist or forearm surgery
Multiple showed no clear difference in secondary analgesia failure ‐ intraoperative sedation required compared with single‐injection technique (high certainty).
1 finding from 1 review
Live birth rate per woman · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
It is very uncertain whether day 3 changes live birth rate per woman compared with day 2 embryo transfer following IVF or ICSI (very low certainty).
1 finding from 1 review
Ongoing pregnancy · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
It is very uncertain whether day 3 changes ongoing pregnancy rate per woman compared with day 2 embryo transfer following IVF or ICSI (very low certainty).
1 finding from 1 review
Clinical pregnancy rate · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
It is very uncertain whether day 3 changes clinical pregnancy rate per woman compared with day 2 embryo transfer following IVF or ICSI (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
Day 3 showed no clear difference in multiple pregnancy rate per woman compared with day 2 embryo transfer following IVF or ICSI (moderate certainty).
1 finding from 1 review
Miscarriage · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
Day 3 showed no clear difference in miscarriage rate per woman compared with day 2 embryo transfer following IVF or ICSI (moderate certainty).
1 finding from 1 review
Complications during pregnancy per woman per couple ‐ ectopic pregnancy4 · Women undergoing in vitro fertilisation or intracytoplasmic sperm injection
Day 3 showed no clear difference in ectopic pregnancy rate per woman compared with day 2 embryo transfer following IVF or ICSI (low certainty).
1 finding from 1 review
Function ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
1 finding from 1 review
Pain VAS 0‐100 (higher means worse) · carpal tunnel syndrome
1 finding from 1 review
Health‐related quality of life ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · carpal tunnel syndrome
It is very uncertain whether surgery changes adverse effects compared with corticosteroid injection (very low certainty).
1 finding from 1 review
Need for surgery or secondary surgery during · carpal tunnel syndrome
It is very uncertain whether surgery changes need for surgery or secondary surgery during compared with corticosteroid injection (very low certainty).
1 finding from 1 review
Clinical improvement ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
It is very uncertain whether surgery changes clinical improvement ‐ Long‐term improvement: > 3 months compared with corticosteroid injection (very low certainty).
1 finding from 1 review
Symptoms ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
1 finding from 1 review
Overall survival · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of people with ≥ 1 serious adverse events · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found